Health Care & Life Sciences » Pharmaceuticals | Rohto Pharmaceutical Co. Ltd.

Rohto Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Rohto Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
MFS International Value Fund
5,656,500
4.8%
0
0.6%
07/31/2018
Sparx Asset New International Blue Chip Japan Equity Fund
2,149,099
1.82%
191,299
7.42%
03/27/2017
2,057,500
1.75%
34,200
5.76%
04/30/2018
Nomura Asset TOPIX ETF Fund (1306)
1,734,500
1.47%
27,500
0.08%
07/31/2018
Oppenheimer International Small Company Fund
1,515,333
1.29%
-183,000
0.46%
02/28/2018
Vanguard Total International Stock Index Fund
1,386,370
1.18%
24,100
0.01%
07/31/2018
Government Pension Fund - Global (The)
1,181,799
1%
-110,501
0%
12/31/2017
IVA Worldwide Fund
1,024,000
0.87%
-25,100
0.4%
03/31/2018
IVA International Fund
1,011,000
0.86%
0
0.81%
12/31/2017
855,000
0.73%
-551,499
1.89%
03/23/2017

About Rohto Pharmaceutical Co.

View Profile
Address
1-8-1 Tatsumi-nishi
Osaka Osaka 544
Japan
Employees -
Website http://www.rohto.co.jp
Updated 07/08/2019
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.